Category: News
-
Is One Answer Good Enough for All? Defining Value in Healthcare
While it makes sense for value assessment to be woven into healthcare decision making, relying on a single method to measure value and using this metric to restrict treatment access is shortsighted. IVI’s Jennifer Bright and Mark Linthicum address this concern in a recent article for the American Journal of Managed Care (AJMC). Read the…
-
IVI Provides Insight into CVS Health’s Decision to Include Cost-per-QALY Analyses from ICER into Formulary Decision-Making
CVS Health’s pharmacy benefit management (PBM) division, CVS Caremark, recently announced their decision to rely exclusively on the analyses of the Institute for Clinical and Economic (ICER) in a new drug management program. IVI’s Director of Scientific Communications, Mark Linthicum, responds to this story in MedCity stating, “The neat ‘answer’ regarding the value of treatment…
-
Why Quality Measures Must Reflect Patient Values, Care Experience
There isn’t an easy answer to assessing value in healthcare, but IVI is working to tackle the problems through considerable research and experimentation by developing an open-source value platform that considers no only clinical factors, but patient perspectives as well. In a recent interview with PatientEngagementHIT.com, IVI’s Jennifer Bright (Executive Director) and Mark Linthicum (Director…
-
Is Using Centralized Value Assessment to Make Centralized Pricing Decisions the Most Effective Path Forward?
The Pink Sheet article described comment letters to HHS’ drug pricing blueprint recommending that cost-effectiveness analyses by ICER could help promote value-based pricing in government-sponsored insurance. While IVI concurs value assessment is noble, worthwhile and needed, IVI cautions about making centralized pricing decisions based on centralized value assessments within the U.S.’s current decentralized health care…
-
IVI Leadership Invited to Speak at the 2018 BIO International Convention
The 2018 BIO International Convention will be held in Boston, MA from June 4th through June 7th. IVI’s Jennifer Bright (Acting Executive Director) and Mark Linthicum (Director of Scientific Communications) are among the speakers invited to the 2018 BIO International Convention, where they will be discussing value assessment frameworks and patient value. The description of…
-
IVI Demonstrates Commitment to Patient Involvement with Release of “Partnering with Patients” Principles
To demonstrate IVI’s commitment to patient involvement and ensure that the patient perspective is represented in our work, IVI recently developed several documents enumerating the principles and practices that guide this vital partnership. These documents offer detail about the actions IVI takes to involve patients and patient organizations early and often in research, model development and other projects, and establish a basis…
-
IVI-RA Value Tool Featured on ISPOR Student Webinar Series
Devin Incerti, Lead Economist on IVI’s Open-Source Value Project, will be presenting the IVI-RA Value Tool as one of ISPOR’s featured student webinars. See below for the full description and details on the webinar, as well as the registration link. WEBINAR: Developing Flexible, Iterative, and Transparent Decision Models: A Detailed Look at the Rheumatoid Arthritis…
-
IVI-Sponsored Health Affairs Policymaker Forum Assembles Key Stakeholders
On September 13th, the Innovation and Value Initiative was proud to sponsor a special Health Affairs briefing in Washington, D.C. Over 200 of the country’s most influential health care stakeholders and public policy thought leaders gathered to address the topic of value in health care. Focusing on “Understanding the Value of Innovations in Medicine,” this…
-
IVI’s Lakdawalla and Balch Participate in NPAF Consortium
On May 17th, IVI’s Executive Director, Darius Lakdawalla, and Panel of Health Advisors member, Alan Blach, spoke at the National Patient Advocate Foundation’s (NPAF) Spring 2017 Policy Consortium. The event launched the NPAF “Roadmap to Clarity in Healthcare Decision-Making.” Both NPAF and IVI are committed to providing patients with accessible and useful information about the…
-
Baumgardner Participates in Becker Friedman Institute’s Health Care Reform Panel
On May 22nd, James Baumgardner, who provides legislative policy expertise as a part of IVI’s Scientific Advisory Group, was an invited panelist for a forum at The University of Chicago’s Becker Friedman Institute. On the panel, titled “The Economic Consequences of Health Care Reform,” Baumgardner applied his past experience as a 20-year veteran of the…